InMed Pharmaceuticals Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Vancouver
INM chart
What traders are saying about $INM
Latest postsInMed Pharmaceuticals Inc. news
- Working capital per share of InMed Pharmaceuticals Inc. – NASDAQ:MTRI
TradingView ·
- Form 4 InMed Pharmaceuticals Inc.: ADAR1 Capital Management, LLC (10% Owner) For: 5 November By Investing.com
Investing.com India ·
- After a 1-for-10 reverse split, ADAR1 funds buy 2,640 InMed Pharmaceuticals (INM) shares.
Stock Titan ·
- InMed Pharmaceuticals Inc. Financial Statements – NASDAQ:MTRI
TradingView ·
- InMed Pharmaceuticals Inc. Dividends – NASDAQ:MTRI
TradingView ·
- InMed Pharmaceuticals Inc. Income Statement – NASDAQ:MTRI
TradingView ·
- InMed Pharmaceuticals Completes Merger, Begins Nasdaq Trading
TipRanks ·
- Form 8K InMed Pharmaceuticals Inc. For: 9 November By Investing.com
Investing.com UK ·
- Mentari Therapeutics to Present at Upcoming Investor Conferences
Yahoo Finance ·
- Mentari Therapeutics Announces Closing of Merger with InMed Pharmaceuticals and Previously Announced $490 Million Financing
Yahoo Finance ·
- Fox-Roku’s $22B Deal, A New Nasdaq Biotech And A $25B Chemicals Tie-Up: Deals Investors Are Watching
stocktwits.com ·
- Mentari Therapeutics Completes InMed Pharmaceuticals Merger Following Approximately $490 Million In Financing
Pulse 2.0 ·
InMed Pharmaceuticals Inc. key financials
| USD | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Revenue | – | $4.9M | $4.6M | $4.1M |
| Net income | -$12.6M | -$1.7M | -$7.7M | -$7.9M |
| Diluted EPS | $-3.12 | $-8.36 | $-20.14 | $-3.25 |
| Total assets (year end) | – | $11.2M | $8.5M | $15.3M |
| Cash and equivalents (year end) | – | $7.0M | $3.4M | $9.5M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
- 8-K8-K
- 8-KFORM 8-K
- 8-K8-K
- 8-KFORM 8-K
- 10-QQUARTERLY REPORT
- 8-KCURRENT REPORT
- 10-KANNUAL REPORT
- 8-KCURRENT REPORT
- 8-KCURRENT REPORT
- 8-KFORM 8-K
- 8-KCURRENT REPORT
- 8-KFORM 8-K
About InMed Pharmaceuticals Inc.
- Ticker
- INM (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Vancouver
- Incorporated in
- British Columbia, Canada
- Fiscal year end
- June 30
- SEC CIK
- 1728328
Frequently asked questions
What exchange is InMed Pharmaceuticals Inc. listed on?
InMed Pharmaceuticals Inc. trades on the Nasdaq under the ticker symbol INM.
What industry is InMed Pharmaceuticals Inc. in?
InMed Pharmaceuticals Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is InMed Pharmaceuticals Inc. headquartered?
InMed Pharmaceuticals Inc.'s business address on file with the SEC is in Vancouver.
When does InMed Pharmaceuticals Inc.'s fiscal year end?
InMed Pharmaceuticals Inc.'s fiscal year ends on June 30.
How much revenue did InMed Pharmaceuticals Inc. report?
InMed Pharmaceuticals Inc. reported $4.9M in revenue for calendar year 2025, according to its SEC filings.